AGG vs BND vs LQD vs VCIT: Which Fits Each Goal in 2026?

Overview

These four ETFs span the core U.S. bond market, from broad-based aggregates to corporate-focused strategies. AGG and BND track the full taxable bond universe (Treasuries, mortgages, corporates, and bonds of other issuers), while LQD and VCIT zero in on investment-grade corporate bonds. The key dividing line is scope: AGG and BND are diversified barometers of overall bond returns; LQD and VCIT isolate corporate credit risk and offer higher yields in exchange.

How they differ

AGG and BND are nearly interchangeable—both track Bloomberg aggregate indexes, charge 0.03% in fees, sport identical monthly distributions, and hold $138B and $162B in AUM respectively. The practical difference is index construction: BND uses a float-adjusted version that reweights larger issues, while AGG uses the standard index. Both yield around 4.16–4.17%.

LQD and VCIT diverge on scope and duration. LQD holds the full investment-grade corporate bond universe (all maturities) tracked by the Markit iBoxx index and carries a 1.36 beta; VCIT restricts itself to intermediate-term corporates (typically 5–10 years) with a 1.07 beta. LQD yields 5.17%, VCIT 5.05%, and LQD's expense ratio is 0.14% versus VCIT's 0.04%. The corporate strategies yield roughly 1% above the aggregate funds, reflecting credit spread premiums.

Who each is best for

AGG: Investors building a core fixed-income allocation who want the broadest possible U.S. bond exposure at minimal cost. Fits households seeking a stable foundation that includes Treasuries, agencies, mortgages, and investment-grade corporates.

BND: Holders preferring Vanguard's ecosystem or those who value float-adjusted weighting to match market cap more closely. Designed for investors wanting aggregate bond exposure with a fund that tilts slightly toward the market's largest issues.

LQD: Investors comfortable with corporate credit risk who prioritize higher current yield and want all-maturity investment-grade corporate bonds. Fits income seekers with intermediate to long time horizons who accept the interest-rate duration and credit volatility that corporates bring.

VCIT: Those seeking corporate yield above aggregates but with less duration risk than LQD. Designed for intermediate-term portfolios where shorter maturity constraints reduce sensitivity to rising rates.

Key risks to know

• Corporate credit spread risk: LQD and VCIT both concentrate on investment-grade corporate bonds. In a widening-spread environment (recession concerns, credit stress), these holdings can decline sharply regardless of Treasury moves. The 1.36 beta on LQD reflects this amplified sensitivity.

• Interest-rate duration mismatch: AGG and BND hold a mix of short, intermediate, and long bonds; a rapid rate rise can pressure NAV broadly, though the all-maturity structure cushions single-duration risk. LQD and VCIT face comparable duration drift but within narrower segments (all corporates vs. intermediate corporates).

• Negative carry in low-yield environments: When yields fall and distribution rates compress below historical averages, funds may distribute less capital gain or rely more on return-of-capital, eroding NAV over time if yields don't recover.

• Mortgage extension risk in AGG and BND: Both hold Agency mortgage-backed securities, which can see duration extend unexpectedly if refinancing slows during rising-rate cycles, locking in longer-than-assumed interest-rate sensitivity.

Bottom line

AGG and BND offer near-identical broad bond diversification at razor-thin costs and 4.16–4.17% yields; the choice between them hinges on whether float adjustment and Vanguard's platform matter to you. LQD and VCIT trade that diversification for corporate credit yield—roughly 1% more—at the cost of higher credit and duration risk. If you want the full bond market in one holding, AGG or BND fits; if you've decided to tilt toward corporate credit for higher income, VCIT's shorter duration and lower fees offer a gentler entry than LQD's full-maturity exposure. Past performance doesn't predict future results.